Complement dependency of cardiomyocyte release of mediators during sepsis
Open Access
- 8 April 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (7), 2500-2508
- https://doi.org/10.1096/fj.11-183236
Abstract
We have recently shown that antibody-induced blockade of C5a, C5a receptors, or IL-17A greatly reduced the harmful outcomes of sepsis. In the current study, normal cardiomyocytes from young (300 g) male Sprague-Dawley rats responded in vitro to C5a (ED50=55 nM) with release of IL-6 and TNFα, peaking between 2 to 8 h. Neutralizing antibodies to mouse C5a or IL-17A (ED50=40 μg for each, based on improved survival) reduced spontaneous in vitro release of cardiosuppressive cytokines and chemokines in cardiomyocytes obtained from mice with polymicrobial sepsis. A non-neutralizing C5a antibody had no such effects. Cardiomyocytes from septic mice (C57Bl/6) showed increased mRNA for TNFR1, IL-6 (gp80), and C5aR at 6 h after sepsis. Cardiomyocytes from septic C5aR–/– or C5L2–/– mice did not show spontaneous in vitro release of cytokines and chemokines. These data suggest that cardiomyocytes from septic mice release suppressive cytokines in a C5a-, C5aR-, and IL-17A-dependent manner, followed by mediator reactivity with receptors on cardiomyocytes, resulting in defective contractility and relaxation. These data may be relevant to a strategy for the treatment of heart dysfunction developing during sepsis.—Atefi, G., Zetoune, F. S., Herron, T. J., Jalife, J., Bosmann, M., Chen, A., Al-Aref, R., Sarma, J. V., Ward, P. A. Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB J. 25, 2500–2508 (2011). www.fasebj.orgKeywords
This publication has 31 references indexed in Scilit:
- Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heartJCI Insight, 2009
- Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in miceJCI Insight, 2009
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Harmful molecular mechanisms in sepsisNature Reviews Immunology, 2008
- Functional roles for C5a receptors in sepsisNature Medicine, 2008
- Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP InhibitorsCardiovascular Drug Reviews, 2007
- Septic shock: a heart story since the 1960sIntensive Care Medicine, 2006
- An essential role for complement C5a in the pathogenesis of septic cardiac dysfunctionThe Journal of Experimental Medicine, 2005
- Inhibition of C5 or absence of C6 protects from sepsis mortalityImmunobiology, 2004
- Protective effects of anti‐C5a peptide antibodies in experimental sepsisThe FASEB Journal, 2001